Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
for
Central Nervous System Tumor, Diffuse Intrinsic Pontine Glioma,
Location: Seattle WA
Sponsor: Seattle Children's Hospital
Sex: All
Age: 1 - 26
Code: NCT04185038
Phase1, Recruiting
Active & Responsive
A Phase 1b, Open-Label Study Of REC-617, A Selective CDK7 Inhibitor, In Patients With Metastatic Or Unresectable RB1-Negative Leiomyosarcoma After Prior Systemic Therapy
for
Phase 1b, Open Label, REC-617, RB1-Negative, Leiomyosarcoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07633756
Phase1, Recruiting
Active & Responsive
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
for
AML (Acute Myeloid Leukemia), Glioma, Cholangiocarcinoma,
Location: New York NY, Orange CA
Sponsor: Rigel Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07486713
Recruiting
Active & Responsive
Phase 1 Trial of D2C7-IT in Combination With 2141-V11 for Recurrent Malignant Glioma
for
Glioma, Malignant
Location: Durham NC
Sponsor: Darell Bigner
Sex: All
Age: 18+
Code: NCT04547777
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
FUS Etoposide for DMG
for
Diffuse Intrinsic Pontine Glioma,
Location: New York NY
Sponsor: Columbia University
Sex: All
Age: 4 - 21
Code: NCT05762419
Phase1, Recruiting
New
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
Location: The Bronx NY, New York NY, Bel Air MD, Glen Burnie MD,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT07452458
Phase3, Recruiting
New
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
for
Phase 1, NK Cell, IL13Ra, EGFRvIII,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07579208
Phase1, Recruiting
New
Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma
for
Glioblastoma, IDH-Wildtype
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT07708961
Phase2, Recruiting
Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma
for
Glioblastoma Multiforme
Location: Montreal, Calgary
Sponsor: Bassam Abdulkarim
Sex: All
Age: 18 - 70
Code: NCT02928575
Phase2, Recruiting
A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
for
Glioblastoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06672575
Phase1, Phase2, Recruiting
Prospective Surgical Study on the Pattern of Electrical Activity in High Grade Glioma as a Predictor of Progression
for
High Grade Glioma, Glioblastoma
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT05565118
Phase1, Recruiting
A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment
for
Glioblastoma Multiforme
Location: Durham NC, Los Angeles CA, Santa Monica CA,
Sponsor: Cedars-Sinai Medical Center
Sex: All
Age: 18+
Code: NCT05708352
Phase2, Recruiting
Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions
for
Glioma, Glioblastoma,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT04047264
Recruiting
FDG and FDOPA PET Demonstration of Functional Brain Abnormalities
for
Glioblastoma
Location: Charlottesville VA
Sponsor: University of Virginia
Sex: All
Age: 18+
Code: NCT04315584
Early_phase1, Recruiting
Key Longitudinal Associations With Risk and Glioblastoma Outcomes
for
Glioblastoma
Location: Durham NC
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06625684
Recruiting
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis